LGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) in Advanced BRAF Melanoma
Clinical trial NCT02159066 · COMPLETED
Trial details
- NCT number
- NCT02159066
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-23
- Primary completion
- 2023-01-10
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.